HANALL BIOPHARMA CO.,LTD

009420 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩50,100.00
-4.75%
Delayed · cached 15 min

Fair value analysis

Reported earnings per share are negative or zero, so the earnings-based models cannot produce a value.

Financial DNA score 13 / 100

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.